Memantine treatment for mild to severe Alzheimer's disease:: Clinical trials summary

被引：0
|
作者：
Tariot, PN
Doody, R
Peskind, E
Winblad, B
Stöffler, A
Graham, SM
McDonald, S
机构：
[1] Univ Rochester, Rochester, NY 14627 USA
[2] Baylor Med Sch, Houston, TX USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Karolinska Inst, Huddinge, Sweden
[5] Merz Pharmaceut GmbH, Frankfurt, Germany
[6] Forest Res Inst, Jersey City, NJ USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80335-X
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S99 / S100
页数：2
相关论文
共 50 条
  • [1] Memantine treatment for mild to severe Alzheimer's disease:: Clinical trials summary
    Tariot, PN
    Doody, R
    Peskind, ER
    Winblad, B
    Stöffler, A
    Graham, SM
    Jonas, JM
    McDonald, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S381 - S381
  • [2] Memantine treatment for mild to severe Alzheimer's disease:: Clinical trials summary
    Tariot, P. N.
    Doody, R.
    Peskind, E. R.
    Winblad, B.
    Stoeffler, A.
    Graham, S. M.
    McDonald, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 194 - 194
  • [3] Memantine treatment for mild to severe Alzheimer's disease: Clinical trials summary
    Tariot, PN
    Doody, RS
    Peskind, ER
    Winblad, B
    Stoeffler, A
    Moebius, HJ
    Graham, SM
    McDonald, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S327 - S328
  • [4] Memantine benefit on cognition in mild to severe Alzheimer's disease
    Mecocci, P.
    Hefting, N.
    Loft, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 186 - 186
  • [5] Memantine in mild cognitive impairment and mild dementia of Alzheimer's disease: theoretical background, clinical trials and recommendations
    Sobow, Tomasz
    AKTUALNOSCI NEUROLOGICZNE, 2014, 14 (01): : 54 - 60
  • [6] Efficacy of Memantine for cognitive deficits of mild to severe Alzheimer's disease
    Schmitt, FA
    Van Dyck, C
    Feldman, H
    Tariot, PN
    Peskind, ER
    Graham, SM
    Bell, JM
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S131 - S131
  • [7] Effect of memantine on behavioral outcomes in mild to severe Alzheimer's disease
    Cummings, JL
    Schneider, E
    Peskind, ER
    Tariot, PN
    Graham, SM
    Bell, JM
    NEUROLOGY, 2005, 64 (06) : A104 - A104
  • [8] Memantine in moderate to severe Alzheimer's disease:: a meta-analysis of randomised clinical trials
    Winblad, Bengt
    Jones, Roy W.
    Wirth, Yvonne
    Stoffler, Albrecht
    Mobius, Hans Jorg
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (01) : 20 - 27
  • [9] Memantine in the treatment of mild-to-moderate Alzheimer's disease
    Cosman, Kelly M.
    Boyle, Llsa L.
    Porsteinsson, Anton P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 203 - 214
  • [10] Memantine for the treatment of Alzheimer's disease: Tolerability and safety data from clinical trials
    Farlow M.R.
    Graham S.M.
    Alva G.
    Drug Safety, 2008, 31 (7) : 577 - 585
12345